Yüklüyor......
Desmopressin and bleeding risk after percutaneous kidney biopsy
BACKGROUND: Desmopressin is used to reduce bleeding after kidney biopsy but evidence supporting its use is weak, especially in patients with elevated creatinine. The present study was undertaken to evaluate efficacy of desmopressin in reducing bleeding after percutaneous kidney biopsy. METHODS: Retr...
Kaydedildi:
| Yayımlandı: | BMC Nephrol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858772/ https://ncbi.nlm.nih.gov/pubmed/31730448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1595-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|